Articles of note for people dealing with pituitary disease and related conditions.
The latest from pharmaceutical companies and healthcare organizations
Brief, insightful commentary from Dr. Lewis Blevins on issues of relevance to pituitary disease.
Dr. Francesca Galbiati discusses oxytocin and its use in hypopituitarism and obesity at ENDO 2025
Dr. Lewis Blevins caught up with Dr. Francesca Galbiati at The Endocrine Society Meeting in San Francisco, California in July 2025. In this video she reviews her work relating to the effects of intranasal oxytocin on sex steroid levels in obese patients.
ENDO 2025: Adrenalectomy Benefits for People with Mild Autonomous Cortisol Secretion (MACS)
Dr. Lewis Blevins talks with Dr. Iacopo Chiodini at The Endocrine Society Meeting in San Francisco, California to discuss his presentation illustrating the benefits of adrenalectomy in patients with MACS. In this video, capturing the presentation of data, they also discuss the need for studies to address the medical management of patients with MACS.
Worth noting:
Recordati announces FDA approval of ISTURISA® new indication in the U.S. to treat endogenous hypercortisolemia in patients with Cushing’s syndrome,- Learn more here
Corcept Therapeutics announces FDA Relacolirant new drug application to treat Hypercortisolism . Read more
From Crinetics Pharmaceuticals – FDA accepts Crinetics new drug Paltusotine’s application for adults with acromegaly . Read more
Camurus announces final results for the once-monthly octreotide subcutaneous treatment option for acromegaly. Read more
New support site from Chiesi; Rethink acromegaly
Pfizer announces Together with Acromegaly patient support site and Together for Rare: Understanding your insurance options video.
Chiesi relaunches a patient-facing website for Mycapssa.
Content for physicians and healthcare professionals.
Join a drug trial. Find out how. Here’s a partial list of studies.
Latest trends and a roundup of health and wellness news
The Podcast
Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
Live Talk on Demand
I recently had the pleasure of meeting Camurus CEO Fredrik Tiberg. We initially connected on a Zoom call and later met at the European Endocrine Conference held in Copenhagen, Denmark in May. We agreed to meet in person, learn more about the company and record a podcast.
Apple Podcasts
Spotify
Amazon Music
Google Podcasts
